Zdrowie i gospodarka · 28/11/1994

FDA Corrects Adverse Experience Reporting Proposal for Human Drugs and Licensed Biological Products

The Food and Drug Administration (FDA) is correcting two errors in a proposal published in the Federal Register on October 27, 1994, which aimed to amend the agency's adverse experience reporting regulations for human drugs and licensed biological products.